TI
IMMU

TT International’s Immunomedics Inc IMMU Stock Holding History

TT International’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$528K Buy
+6,210
New +$314K 0.03% 51

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

TT International's IMMU Position: Q3 2020 in Review

TT International opened a new position in Immunomedics Inc (IMMU) in Q3 2020: 6,210 shares worth $528K. The stake represents 0.03% of the portfolio and ranks #51 among its holdings.

408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • TT International held 6,210 shares of Immunomedics Inc worth $528K as of Q3 2020.
  • Immunomedics Inc was a new TT International position in Q3 2020.
  • Immunomedics Inc made up 0.03% of TT International's portfolio in Q3 2020, its #51 holding.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on TT International's 13F filing for Q3 2020, filed 13 Nov 2020.